Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background Chronic kidney disease is a major global health problem, significantly increasing the risk of cardiovascular complications compared to the general population. This study aimed to evaluate vascular aging in patients with end-stage renal disease treated with hemodialysis or peritoneal dialysis by analyzing clinical and laboratory parameters and carotid intima-media thickness (CIMT), with the goal of identifying predictors of carotid disease and comparing the prevalence between groups. Methods We conducted a retrospective cohort study that included 59 subjects with end-stage renal disease who were treated with renal replacement therapy: peritoneal dialysis (29 subjects) and hemodialysis (30 subjects). Results When observing these parameters collectively, it was noted that at least one of the parameters (intima-media thickness greater than 0.7 mm or stenosis of the carotid arteries) was statistically more frequently present in the group of patients treated with the peritoneal dialysis method compared to those treated with the hemodialysis method (72.4% vs. 46.7%; p=0.044). The correlation analysis showed that pathological findings on the carotid blood vessels statistically significantly correlated with assignment to the group treated with peritoneal dialysis (r=-0.262, p=0.045). According to the results of multivariate logistic regression analysis, the independent factor associated with carotid disease belonged to the peritoneal dialysis group (odds ratio=3.24; 95% confidence interval=1.00-13.47). Subjects treated with peritoneal dialysis had a 3.244 times greater chance of developing carotid disease. Conclusion Monitoring clinical and laboratory parameters and changes in carotid blood vessels is important in patients with chronic kidney disease to prevent carotid atherosclerotic disease and other cardiovascular diseases. In our study, patients undergoing peritoneal dialysis had a 3.244 times higher likelihood of developing carotid disease. A careful selection of dialysis modality may influence the slowing of carotid atherosclerotic disease progression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12413551PMC
http://dx.doi.org/10.7759/cureus.89519DOI Listing

Publication Analysis

Top Keywords

peritoneal dialysis
28
carotid disease
16
treated peritoneal
12
carotid
11
disease
10
dialysis
9
carotid arteries
8
chronic kidney
8
kidney disease
8
end-stage renal
8

Similar Publications

Background: Balancing the risks of thrombotic and bleeding events in people with advanced kidney disease is a clinical challenge.

Objectives: To estimate rates of major adverse thrombotic events (MATEs) and bleeding events in individuals with chronic kidney disease (CKD) stages 4 or 5 or with end-stage kidney disease (ESKD) receiving hemodialysis (HD) or peritoneal dialysis (PD).

Methods: Using administrative claims from a 20% Medicare sample, Optum's de-identified Clinformatics Data Mart Database, and the US Renal Data System from 2016-2019, we identified individuals with CKD stages 4 or 5 and individuals with dialysis-dependent ESKD.

View Article and Find Full Text PDF

Background: Chronic kidney disease (CKD) is associated with a higher prevalence of valvular diseases and increased mortality from cardiovascular causes. Factors that influence the genesis of cardiac valve calcification (CVC) in these patients are not well-defined.

Objective: To determine the risk factors for valvular calcification in patients with CKD.

View Article and Find Full Text PDF

Objective: Minimal Invasive Dialysis Access (MIDA) for renal dialysis encompasses percutaneous arteriovenous fistula (pAVF) creation and the modified percutaneous Seldinger peritoneal dialysis catheter insertions (pPD). This review examines the impact of MIDA on technical success, maturation rates, patency, clinical benefits, complications, and cost.

Methods: A review was made of the literature on MIDA including pAVF creation and pPD insertion regarding technical success rates, maturation rates, patency, clinical benefits, complications, and cost.

View Article and Find Full Text PDF

Background: Experience with icodextrin use in children on long-term peritoneal dialysis is limited. We describe international icodextrin prescription practices and their impact on clinical outcomes: ultrafiltration, blood pressure control, residual kidney function (RKF), technique and patient survival.

Methods: We included patients under 21 years enrolled in the International Pediatric Peritoneal Dialysis Network (IPPN) between 2007 and 2024, on automated PD with a daytime dwell.

View Article and Find Full Text PDF